62247-2 |
Observation |
DistWidth |
RBC^Fetus |
Pt |
Qn |
Automated count |
|
ACTIVE |
Erythrocyte [DistWidth] in Red Blood Cells from Fetus by Automated count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
62247-2 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
RDW RBC Fetus Auto |
|
|
|
N |
|
Auto; Automated detection; Elec; Elect; Electr; Erythrocytes; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.79 |
2.34 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
62248-0 |
Erythrocytes.nucleated |
NCnc |
Bld^Fetus |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated erythrocytes [#/volume] in Blood from Fetus by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
62248-0 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
nRBC # Bld Fetus Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood |
2.7 |
2.34 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
62249-8 |
Reticulocytes |
NCnc |
Bld^Fetus |
Pt |
Qn |
Automated count |
|
ACTIVE |
Reticulocytes [#/volume] in Blood from Fetus by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
62249-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Retics # Fetus Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fetal; Gyn; Gynecology; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; WB; Whole blood |
2.7 |
2.34 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
6225-7 |
Rat serum proteins Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Rat serum proteins IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6225-7 |
|
|
|
|
Both |
|
|
|
0 |
Rat Serum Prot IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e75; Immune globulin E; Immunoglobulin E; Point in time; Protein; QNT; Quan; Quant; Quantitative; Random; Ser; Serum; SR |
2.73 |
1.0d |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
62250-6 |
Reticulocytes.immature/Reticulocytes.total |
NFr |
Bld^Fetus |
Pt |
Qn |
Automated count |
|
ACTIVE |
Immature reticulocytes/Reticulocytes.total in Blood from Fetus by Automated count |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
62250-6 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Imm Retics NFr Fetus Auto |
|
|
|
N |
|
Auto; Automated detection; Blood; Elec; Elect; Electr; Fetal; Gyn; Gynecology; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Imm; Imm Retics; Immat; IRF; Number fraction; OB; ObGyn; Obstetrics; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; Shift cells; Stress cells; Tot; Totl; WB; Whole blood |
2.73 |
2.34 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
62251-4 |
Leukocytes |
NCnc |
Plr fld^Fetus |
Pt |
Qn |
Automated count |
|
ACTIVE |
Leukocytes [#/volume] in Pleural fluid from Fetus by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*6/L |
|
|
|
|
|
|
HEM/BC |
|
62251-4 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
WBC # Plr Fetus Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.7 |
2.34 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
62252-2 |
Cells.CD79/Cells |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD79 cells/cells in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
62252-2 |
|
|
|
|
Observation |
|
|
|
0 |
CD79 cells NFr Bld |
|
|
|
N |
|
Blood; CD79 cells; Cell; CELL MARKERS; Cellularity; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.79 |
2.34 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
62253-0 |
Lipoprotein.alpha |
EntLen |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipoprotein.alpha [Entitic length] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nm |
|
|
|
|
|
|
CHEM |
|
62253-0 |
|
|
|
|
Observation |
|
|
|
0 |
HDL SerPl Qn |
|
|
|
N |
|
Alfa; Chemistry; Entitic length; HDL; High density lipoproteins; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.34 |
|
|
|
|
|
|
|
nm |
|
|
|
0 |
62254-8 |
Lipoprotein.pre-beta |
EntLen |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipoprotein.pre-beta [Entitic length] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nm |
|
|
|
|
|
|
CHEM |
|
62254-8 |
|
|
|
|
Observation |
|
|
|
0 |
VLDL SerPl Qn |
|
|
|
N |
|
B; Before; Chemistry; Entitic length; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Very low density lipoproteins; VLDL |
2.73 |
2.34 |
|
|
|
|
|
|
|
nm |
|
|
|
0 |
62255-5 |
Lipoprotein insulin resistance score |
Score |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipoprotein insulin resistance score in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
Index |
|
|
|
|
|
|
CHEM |
|
62255-5 |
|
|
|
|
Observation |
|
|
|
0 |
LP-IR score SerPl |
|
|
|
N |
|
Chemistry; HUM; Humulin; IH7; Insul; Insulin resist score; Lente; Lip; Lipoprot; Lipoproteins; LP; LP-IR score; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Resist; Resistanc; Resistant; Resistent; Scale; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente |
2.73 |
2.34 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
62256-3 |
Bacterial aminoglycoside resistance aacA gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Aminoglycoside resistance aacA gene [Presence] by Molecular method |
|
NAM |
DefinitionDescription |
|
|
|
DETECTED/NOT DETECTED |
|
|
|
|
|
ABXBACT |
|
62256-3 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
aacA Islt/Spm Ql |
|
|
|
N |
|
Amikacin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; Bact; c288; Gentamicin; Islt; Islt/Spm; Isol; Molecular genetics; Neomycin; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Streptomycin; Tobramycin |
2.65 |
2.34 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Removed parentheses around gene name, updated System from "XXX" and Method from "Probe.amp.tar" according to the new, more sustainable model for LOINC molecular resistance terms [Approved by LOINC Laboratory Committee in June 2018]. |
0 |
62257-1 |
Cephalosporin resistance gene |
ACnc |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
DEPRECATED |
Deprecated Cephalosporin resistance gene [Presence] by Probe & target amplification method |
|
MIN |
DefinitionDescription |
|
|
|
Detected / Not Detected |
|
|
|
|
|
ABXBACT |
|
62257-1 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
Deprecated Cephalosporin resis XXX Ql PC |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Arbitrary Concentration; c201; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.34 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62258-9 |
Bacterial erythromyin+clindamycin resistance ermA+ermC genes |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Erythromyin+clindamycin resistance ermA + ermC genes [Presence] by Molecular method |
|
NAM |
DefinitionDescription |
|
|
|
Detected / Not Detected |
|
|
|
|
|
ABXBACT |
|
62258-9 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
ermA+ermC Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Methylase; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Sobelin; Spec; Topical |
2.65 |
2.34 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Removed parentheses around gene names, updated System from "XXX," and Method from "Probe.amp.tar" according to the new, more sustainable model for LOINC molecular resistance terms [Approved by LOINC Laboratory Committee in June 2018] |
0 |
62259-7 |
Methicillin resistance gene |
ACnc |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
DEPRECATED |
Deprecated Methicillin resistance gene [Presence] by Probe & target amplification method |
|
MIN |
DefinitionDescription |
|
|
|
Detected / Not Detected |
|
|
|
|
|
ABXBACT |
|
62259-7 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
Deprecated Methicillin resis XXX Ql PCR |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Arbitrary Concentration; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Spec; Staficyn; Staphicillin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.34 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
6226-5 |
Rat urine proteins Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Rat urine proteins IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6226-5 |
|
|
|
|
Both |
|
|
|
0 |
Rat Urine Prot IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e74; Immune globulin E; Immunoglobulin E; Point in time; Protein; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0d |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
62260-5 |
Bacterial tetracycline resistance tetK+tetM genes |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Tetracycline resistance tetK + tetM genes [Presence] by Molecular method |
|
NAM |
DefinitionDescription |
|
|
|
Detected / Not Detected |
|
|
|
|
|
ABXBACT |
|
62260-5 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
tetK+tetM Islt/Spm Ql |
|
|
|
N |
|
Achromycin V; ANTIBIOTIC SUSCEPTIBILITIES; Bact; C18; c211; C75; Chemiciclina; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; Panmycin; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Tetrabioptal |
2.65 |
2.34 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; ; Updated System from "Isolate" and Method from "Probe.amp.tar" according to the new, more sustainable model for LOINC molecular resistance terms [Approved by LOINC Laboratory Committee in June 2018]. |
0 |
62261-3 |
Bacterial vancomycin resistance vanA+vanB genes |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Vancomycin resistance vanA + vanB genes [Presence] by Molecular method |
|
MIN |
DefinitionDescription |
|
|
|
Detected / Not detected |
|
|
|
|
|
ABXBACT |
|
62261-3 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
vanA+vanB Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; c162; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; VANC; Vancocin; Vancomycin resistance gene; Vancor |
2.73 |
2.34 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Removed parentheses from Component because the contents represent gene names, not acronyms.; Updated System from "Isolate" and Method from "Probe.amp.tar" according to the new, more sustainable model for LOINC molecular resistance terms [Approved by LOINC Laboratory Committee in June 2018]. |
0 |
62262-1 |
PhenX measure - sugar intake |
- |
^Patient |
Pt |
- |
PhenX |
|
DEPRECATED |
Deprecated PhenX measure - sugar intake |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62262-1 |
|
PhenX |
|
|
|
|
|
|
0 |
|
|
PhenX.051000 |
|
N |
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.46 |
2.34 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62263-9 |
PhenX domain - Nutrition and dietary supplements |
- |
^Patient |
Pt |
- |
PhenX |
|
TRIAL |
PhenX domain - Nutrition and dietary supplements |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62263-9 |
|
PhenX |
|
|
|
|
|
|
0 |
Domain - Nutrition DS |
|
PX050000 |
|
N |
|
Domain - Nutrition DS; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.68 |
2.34 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62264-7 |
Carbon dioxide |
VFr/PPres |
Gas delivery system |
Pt |
Qn |
|
|
ACTIVE |
Carbon dioxide [VFr/PPres] in Gas delivery system |
|
MIN |
DefinitionDescription |
|
|
%{vol}; mm[Hg] |
|
|
|
|
|
|
PULM |
|
62264-7 |
|
|
|
|
Both |
|
|
|
0 |
CO2 VFr/PPres Gas DS |
|
|
|
N |
|
Carbonic anhydride; cO2; Gas DS; Gases; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory |
2.7 |
2.56 |
|
|
|
|
|
|
|
%{vol}; mm[Hg] |
|
|
|
0 |
62265-4 |
Desflurane^during expiration |
VFr/PPres |
Airway adaptor |
Pt |
Qn |
|
|
ACTIVE |
Desflurane [VFr/PPres] Airway adaptor --during expiration |
|
MIN |
DefinitionDescription |
|
|
%{vol}; mm[Hg] |
|
|
|
|
|
|
PULM |
|
62265-4 |
|
|
|
|
Both |
|
|
|
0 |
Des during expir VFr/PPres Away adap |
|
|
|
N |
|
Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory |
2.7 |
2.56 |
|
|
|
|
|
|
|
%{vol}; mm[Hg] |
|
|
|
0 |
62266-2 |
Enflurane |
VFr/PPres |
Airway adaptor |
Pt |
Qn |
|
|
ACTIVE |
Enflurane [VFr/PPres] Airway adaptor |
|
MIN |
DefinitionDescription |
|
|
%{vol}; mm[Hg] |
|
|
|
|
|
|
PULM |
|
62266-2 |
|
|
|
|
Both |
|
|
|
0 |
Enf VFr/PPres Away adap |
|
|
|
N |
|
Away adap; Compound 347; Ethrane; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory |
2.7 |
2.54 |
|
|
|
|
|
|
|
%{vol}; mm[Hg] |
|
|
Changed System from "Airway" to "Airway adaptor" to clarify meaning per IEEE 11073:10101a standard and to distinguish the "Airway adaptor" device from "Respiratory system.airway", which is the airway portion of the patient respiratory system. |
0 |
62267-0 |
Halothane |
VFr/PPres |
Airway adaptor |
Pt |
Qn |
|
|
ACTIVE |
Halothane [VFr/PPres] Airway adaptor |
|
MIN |
DefinitionDescription |
|
|
%{vol}; mm[Hg] |
|
|
|
|
|
|
PULM |
|
62267-0 |
|
|
|
|
Both |
|
|
|
0 |
Hal VFr/PPres Away adap |
|
|
|
N |
|
Anestan; Away adap; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan |
2.7 |
2.54 |
|
|
|
|
|
|
|
%{vol}; mm[Hg] |
|
|
Changed System from "Airway" to "Airway adaptor" to clarify meaning per IEEE 11073:10101a standard and to distinguish the "Airway adaptor" device from "Respiratory system.airway", which is the airway portion of the patient respiratory system. |
0 |
62268-8 |
Isoflurane |
VFr/PPres |
Airway adaptor |
Pt |
Qn |
|
|
ACTIVE |
Isoflurane [VFr/PPres] Airway adaptor |
|
MIN |
DefinitionDescription |
|
|
%{vol}; mm[Hg] |
|
|
|
|
|
|
PULM |
|
62268-8 |
|
|
|
|
Both |
|
|
|
0 |
Isofl VFr/PPres Away adap |
|
|
|
N |
|
Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory |
2.7 |
2.54 |
|
|
|
|
|
|
|
%{vol}; mm[Hg] |
|
|
Changed System from "Airway" to "Airway adaptor" to clarify meaning per IEEE 11073:10101a standard and to distinguish the "Airway adaptor" device from "Respiratory system.airway", which is the airway portion of the patient respiratory system. |
0 |
62269-6 |
Isoflurane^during expiration |
VFr/PPres |
Airway adaptor |
Pt |
Qn |
|
|
ACTIVE |
Isoflurane [VFr/PPres] Airway adaptor --during expiration |
|
MIN |
DefinitionDescription |
|
|
%{vol}; mm[Hg] |
|
|
|
|
|
|
PULM |
|
62269-6 |
|
|
|
|
Both |
|
|
|
0 |
Isofl during expir VFr/PPres Away adap |
|
|
|
N |
|
Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory |
2.7 |
2.56 |
|
|
|
|
|
|
|
%{vol}; mm[Hg] |
|
|
|
0 |